Updates (Page 47)

October 26, 2011

Why Isn’t Alzheimer’s Research Keeping Up with the Disease?

Alzheimer’s is the only top 10 killer disease in the U.S. that cannot be prevented, cured or even treated effectively over time. One big barrier: there are not enough volunteers for experimental drug trials for Alzheimer’s disease.
October 13, 2011

And Naked Came the Mole Rat

Here at the Alliance for Aging Research we are huge fans of the African naked mole rat. Now, why would anyone love a 4-inch squinty-eyed hairless wrinkled rodent with buck teeth?
October 7, 2011

One More Step to Reasoned Understanding of Stem-Cell Research

Scientists at the New York Stem Cell Foundation Laboratory have done what scientists do best: they have narrowed the question. By creating cells capable of growing into any cell type in the human body, research is moving us beyond fear mongering over cloning technologies to study these cells as potential weapons against Alzheimer’s, Parkinson’s, diabetes and other medical maladies.
June 30, 2011

PDUFA V Can Help Patients and the FDA

On June 26, 2011 I was interviewed by BioCentury This Week to share the Alliance for Aging Research’s impressions on the fifth reauthorization of the Food and Drug Administration’s Prescription Drug User Fee program. Thanks to Congress, we and other active patient groups were able to lend an early voice in helping to shape how user fees might be used to help speed the delivery of better treatments and cures to patient in need of relief from Alzheimer’s, Cancer, Parkinson’s and many more diseases.  
February 2, 2011

“Rescuing Cognition”: CA vs. Alzheimer’s Disease ~ By Don Reed

This is one of the best articles on Alzheimer's I’ve seen to date. It is written by Don C. Reed, a stem cell activist in California, on the promise of current research, and on embryonic stem cells; bringing attention to a subject that is often forgotten and underfunded.  
January 20, 2011

Sargent Shriver’s Gift

Twenty-five years ago a young lawyer fresh out of Harvard’s Kennedy School of Government came to a fledgling group called the Aging Research Policy Council volunteering free legal services. But first he needed support for pro bono work from his firm’s senior partner, Sargent Shriver.
December 23, 2010

Final Countdown…

For years we have been urging federal funding increases in biomedical research by citing the countdown to the first wave of Baby Boomers turning age 65 and joining the Medicare rolls.
October 21, 2010

A Doctor Who Prefers ‘The Dark Side’

It seems Dr. Carl Elliott has let his instincts as a provocateur get the better of his perspective as a physician and healer. Promoting his book "White Coat, Black Hat: Adventures on the Dark Side of Medicine,” Dr. Elliott, a frequent contributor to The New Yorker and Atlantic Monthly, finds it deplorable that physicians who use drugs to relieve human misery have any actual contact with companies that research, develop and sell those medicines.
July 14, 2010

An Early Salvo

When world class scientists and physicians call for a global project to modify human aging, it is time for policymakers in Washington and elsewhere to take notice.
July 7, 2010

Dr. Robert N. Butler, 1927-2010

The sudden and unexplained death of a beloved grandfather set Robert Neil Butler on the road to be a pioneer in the science and medicine of health and aging.